19:49 , Jun 7, 2019 |  BioCentury  |  Emerging Company Profile

insitro: machine learning with designated data

Just 12 months after announcing the launch of insitro, AI veteran and CEO Daphne Koller has led the drug discovery and machine learning company to a series A round of over $100 million and a...
12:21 , Apr 16, 2019 |  BC Extra  |  Company News

With insitro deal, Gilead turns to machine learning to unlock new NASH targets

Not yet content with the trio of clinical programs in its pipeline, Gilead has struck its third NASH deal this year, this time banking on machine learning company insitro to develop disease models and discover...
18:38 , Feb 5, 2019 |  BC Extra  |  Company News

Management tracks: Amazon-Berkshire Hathaway-JPM venture hires Kutan as CTO

Serkan Kutan started in January as the CTO of the healthcare venture from J.P. Morgan (NYSE:JPM), Berkshire Hathaway Inc. (NYSE:BRK-A; NYSE:BRK-B) and Amazon.com Inc. (NASDAQ:AMZN). He was CTO of Zocdoc Inc. (New York, N.Y.), a...
01:37 , Aug 10, 2018 |  BC Innovations  |  Finance

Super-sized ambitions

A trend toward super-sized initial financings is attracting a new set of deep-pocketed investors to the early stage space. These new players are making earlier commitments with hopes of guaranteeing larger ownership positions at an...
16:28 , Aug 18, 2017 |  BC Week In Review  |  Financial News

Anti-aging company Unity closes $151M series B

Unity Biotechnology Inc. (San Francisco, Calif.) raised $35 million in the second close of a series B round on Aug. 17, bringing the total amount raised in the round to $151 million. New investors in...
23:50 , Aug 17, 2017 |  BC Extra  |  Financial News

Anti-aging company Unity closes $151M series B

Unity Biotechnology Inc. (San Francisco, Calif.) raised $35 million in the second close of a series B round, bringing the total amount raised in the round to $151 million. New investors in the round included...
00:02 , Mar 2, 2017 |  BC Extra  |  Financial News

Grail raises $900M toward planned $1B round

Cancer screening company Grail Inc. (Menlo Park, Calif.) said it raised more than $900 million in the first close of a series B financing. The company expects a second close this quarter that would raise...
22:27 , Jan 6, 2017 |  BioCentury  |  Finance

Billion dollar baby

With what could be more than a $1 billion B round in the works, cancer screening company Grail Inc. is on track to set a new private financing record. The round is expected to close...
07:00 , Oct 31, 2016 |  BC Week In Review  |  Financial News

Unity Biotechnology completes venture financing

Unity Biotechnology Inc. , San Francisco, Calif.  Business: Autoimmune, Ophthalmic, Cardiovascular  Date completed: 2016-10-27  Type: Venture financing  Raised: $116 million  Investors: Arch Venture Partners ; Baillie Gifford; Fidelity; Partner Fund Management; Venrock; Bezos Expeditions; WuXi...
07:00 , Oct 31, 2016 |  BioCentury  |  Tools & Techniques

Slaying senescent cells

  With a whopper of a B round and a new publication demonstrating both a causal role of senescent cells in atherosclerosis, and a therapeutic effect of eliminating them, Unity Biotechnology Inc. is readying to...